Weiwei Xiao

39PUBLICATIONS
144CO-AUTHORS
Entertainment and gamingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Sep 23, 2026
The Reciprocal Relationships Among Impulsivity, Self-Control, Gaming Time, and Internet Gaming Disorder Among Adolescents: Prospective Longitudinal Cohort Study.

|Aug 27, 2026
A Surgical Map Defining High-Risk Anatomical Boundaries for Salvage Endoscopic Nasopharyngectomy.

|Jun 10, 2026
TQB2618 plus Penpulimab, Alone or in Combination with Chemotherapy, for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter, Two-Cohort, Phase II Trial.

|May 18, 2026
Durvalumab plus HAIC-FOLFOX followed by maintenance durvalumab for hepatocellular carcinoma with major portal invasion: phase 2 DurHope study.

|May 14, 2026
HILL: the efficacy and safety of hepatic arterial infusion chemotherapy with the FOLFOX regimen combined with lenvatinib and the PD-L1 inhibitor durvalumab in unresectable hepatocellular carcinoma: a prospective, single-arm, phase 2 clinical trial.

|May 05, 2026
Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 Trial.

Pageof 7

Frequent Collaborators

8 joint publications

Joseph Tf Lau

6 joint publications

Yanqiu Yu

5 joint publications

Jianxin Zhang

4 joint publications

Feng Wang